Search Results 311-320 of 14912 for alt

1. S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer - Mayo Clinic

   ALT and AST ≤ upper limit of normal (ULN)*; Alkaline phosphatase ≤ ULN*; Not pregnant or nursing; Fertile patients must use an effective contraception; No ...

2. A Study of Allopurinol to Relieve Symptoms in Patients with Heart Failure and High Uric Acid Levels - Mayo Clinic

   Evidence of active hepatitis with ALT and AST greater than 3x normal; Any condition other than HF which could limit the ability to perform a 6-minute walk ...

3. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1500/mcL; · Hemoglobin ≥ 9.0 g/dL; · Platelets ≥ 100,000/mcL; · Total bilirubin ≤ 1.5 x the upper limit of normal (ULN); · SGPT (ALT) ...

4. PET Scan Imaging in Assessing Response in Patients with Esophageal Cancer Receiving Combination Chemotherapy - Mayo Clinic

   AST/ALT ≤ 2.5 times ULN; Not pregnant or nursing; Negative pregnancy test; No prior malignancy within 5 years, with the exception of basal or squamous cell ...

5. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   AST/SGOT and ALT/SGPT ≤ 2.5 x ULN or ≤ 5 x ULN if liver metastases. Transfusion and/or erythropoietin not permitted within 1 week prior to blood draw.

6. A Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects with Primary Biliary Cirrhosis - Mayo Clinic

   AST or ALT > 3 × ULN; Total bilirubin > 2 × ULN; Auto-immune hepatitis; Primary sclerosing cholangitis; Known history of alpha-1-Antitrypsin deficiency; Known ...

7. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

   ... ALT/AST \>3x ULN. For patients with hepatic metastases, ALT/AST \>5x ULN is exclusionary. 11. INR or PT or aPTT \> 1.8 × ULN, unless the participant is ...

8. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

   Participation eligibility · AST or ALT ≥ 2 x ULN; · Total bilirubin ≥ 1.5 x ULN. · Females: Hemoglobin < 11 g/dL | Males: hemoglobin < 12 g/dL; · White blood cell ...

9. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   AST/ALT ≤ 3 x ULN; Total bilirubin <1.5 x ULN (except subjects with Gilbert Syndrome who can have total bilirubin <3.0 mg/deciliter). Women of childbearing ...

10. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

    ALT and AST ≤ 2.5 × upper limit of normal (ULN), with the following exception: Patients with documented liver metastases: AST and/or ALT ≤ 5.0 × ULN.